Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8-/- mice

Helen H. Wang, Shailendra B. Patel, Martin C. Carey, David Q.H. Wang

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Sitosterolemia is caused by mutations in either ABCG5 or ABCG8, but simultaneous mutations of these genes have never been observed. To explore whether ABCG8, the sterol efflux (hemi-)transporter, plays a major role in determining intestinal absorption efficiency and hepatic secretion rates of cholesterol and sitostanol, we performed direct measurements of the absorption and lymphatic transport of these sterols in mice with chronic biliary and lymphatic fistulae, as well as the transport rates of radiolabeled cholesterol and sitostanol from plasma high-density lipoprotein (HDL) into bile in male Abcg8-/- and wild-type mice. We observed that the absorption and lymphatic transport rates of radiolabeled cholesterol and sitostanol were increased by ≈40% and ≈=500%, respectively, in Abcg8-/- mice in the setting of constant intraduodenal infusion of micellar taurocholate and lecithin. Both strains displayed identical intestinal Npc1l1 expression levels and small intestinal transit rates. After 45 minutes of intraduodenal infusion, acute intestinal uptake rates of trace [14C] cholesterol and [ 3H] sitostanol were essentially similar in both groups of mice with intact biliary secretion. Furthermore, in wild-type mice, mass transport rate of [3H] sitostanol from plasma HDL into bile was significantly faster than that of [14C]cholesterol; however, no [3H] sitostanol and only traces of [14C] cholesterol were detected in bile of Abcg8-/- mice. Conclusion: Deletion of the Abcg8 gene alone significantly increases the mass of intestinal cholesterol and sitostanol absorption and reduces but does not eliminate hepatic secretion of cholesterol. Moreover, the mutation has no influence on acute uptake of cholesterol and sitostanol by the enterocyte nor small intestinal transit time.

Original languageEnglish (US)
Pages (from-to)998-1006
Number of pages9
JournalHepatology
Volume45
Issue number4
DOIs
StatePublished - Apr 1 2007
Externally publishedYes

Fingerprint

Sterols
Cholesterol
Bile
HDL Lipoproteins
Mutation
Biliary Fistula
Taurocholic Acid
Lecithins
stigmastanol
Enterocytes
Liver
Intestinal Absorption
Gene Deletion

ASJC Scopus subject areas

  • Hepatology

Cite this

Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8-/- mice. / Wang, Helen H.; Patel, Shailendra B.; Carey, Martin C.; Wang, David Q.H.

In: Hepatology, Vol. 45, No. 4, 01.04.2007, p. 998-1006.

Research output: Contribution to journalArticle

Wang, Helen H. ; Patel, Shailendra B. ; Carey, Martin C. ; Wang, David Q.H. / Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8-/- mice. In: Hepatology. 2007 ; Vol. 45, No. 4. pp. 998-1006.
@article{5b6e62ac57ed483681757fe415428f8e,
title = "Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8-/- mice",
abstract = "Sitosterolemia is caused by mutations in either ABCG5 or ABCG8, but simultaneous mutations of these genes have never been observed. To explore whether ABCG8, the sterol efflux (hemi-)transporter, plays a major role in determining intestinal absorption efficiency and hepatic secretion rates of cholesterol and sitostanol, we performed direct measurements of the absorption and lymphatic transport of these sterols in mice with chronic biliary and lymphatic fistulae, as well as the transport rates of radiolabeled cholesterol and sitostanol from plasma high-density lipoprotein (HDL) into bile in male Abcg8-/- and wild-type mice. We observed that the absorption and lymphatic transport rates of radiolabeled cholesterol and sitostanol were increased by ≈40{\%} and ≈=500{\%}, respectively, in Abcg8-/- mice in the setting of constant intraduodenal infusion of micellar taurocholate and lecithin. Both strains displayed identical intestinal Npc1l1 expression levels and small intestinal transit rates. After 45 minutes of intraduodenal infusion, acute intestinal uptake rates of trace [14C] cholesterol and [ 3H] sitostanol were essentially similar in both groups of mice with intact biliary secretion. Furthermore, in wild-type mice, mass transport rate of [3H] sitostanol from plasma HDL into bile was significantly faster than that of [14C]cholesterol; however, no [3H] sitostanol and only traces of [14C] cholesterol were detected in bile of Abcg8-/- mice. Conclusion: Deletion of the Abcg8 gene alone significantly increases the mass of intestinal cholesterol and sitostanol absorption and reduces but does not eliminate hepatic secretion of cholesterol. Moreover, the mutation has no influence on acute uptake of cholesterol and sitostanol by the enterocyte nor small intestinal transit time.",
author = "Wang, {Helen H.} and Patel, {Shailendra B.} and Carey, {Martin C.} and Wang, {David Q.H.}",
year = "2007",
month = "4",
day = "1",
doi = "10.1002/hep.21579",
language = "English (US)",
volume = "45",
pages = "998--1006",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8-/- mice

AU - Wang, Helen H.

AU - Patel, Shailendra B.

AU - Carey, Martin C.

AU - Wang, David Q.H.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Sitosterolemia is caused by mutations in either ABCG5 or ABCG8, but simultaneous mutations of these genes have never been observed. To explore whether ABCG8, the sterol efflux (hemi-)transporter, plays a major role in determining intestinal absorption efficiency and hepatic secretion rates of cholesterol and sitostanol, we performed direct measurements of the absorption and lymphatic transport of these sterols in mice with chronic biliary and lymphatic fistulae, as well as the transport rates of radiolabeled cholesterol and sitostanol from plasma high-density lipoprotein (HDL) into bile in male Abcg8-/- and wild-type mice. We observed that the absorption and lymphatic transport rates of radiolabeled cholesterol and sitostanol were increased by ≈40% and ≈=500%, respectively, in Abcg8-/- mice in the setting of constant intraduodenal infusion of micellar taurocholate and lecithin. Both strains displayed identical intestinal Npc1l1 expression levels and small intestinal transit rates. After 45 minutes of intraduodenal infusion, acute intestinal uptake rates of trace [14C] cholesterol and [ 3H] sitostanol were essentially similar in both groups of mice with intact biliary secretion. Furthermore, in wild-type mice, mass transport rate of [3H] sitostanol from plasma HDL into bile was significantly faster than that of [14C]cholesterol; however, no [3H] sitostanol and only traces of [14C] cholesterol were detected in bile of Abcg8-/- mice. Conclusion: Deletion of the Abcg8 gene alone significantly increases the mass of intestinal cholesterol and sitostanol absorption and reduces but does not eliminate hepatic secretion of cholesterol. Moreover, the mutation has no influence on acute uptake of cholesterol and sitostanol by the enterocyte nor small intestinal transit time.

AB - Sitosterolemia is caused by mutations in either ABCG5 or ABCG8, but simultaneous mutations of these genes have never been observed. To explore whether ABCG8, the sterol efflux (hemi-)transporter, plays a major role in determining intestinal absorption efficiency and hepatic secretion rates of cholesterol and sitostanol, we performed direct measurements of the absorption and lymphatic transport of these sterols in mice with chronic biliary and lymphatic fistulae, as well as the transport rates of radiolabeled cholesterol and sitostanol from plasma high-density lipoprotein (HDL) into bile in male Abcg8-/- and wild-type mice. We observed that the absorption and lymphatic transport rates of radiolabeled cholesterol and sitostanol were increased by ≈40% and ≈=500%, respectively, in Abcg8-/- mice in the setting of constant intraduodenal infusion of micellar taurocholate and lecithin. Both strains displayed identical intestinal Npc1l1 expression levels and small intestinal transit rates. After 45 minutes of intraduodenal infusion, acute intestinal uptake rates of trace [14C] cholesterol and [ 3H] sitostanol were essentially similar in both groups of mice with intact biliary secretion. Furthermore, in wild-type mice, mass transport rate of [3H] sitostanol from plasma HDL into bile was significantly faster than that of [14C]cholesterol; however, no [3H] sitostanol and only traces of [14C] cholesterol were detected in bile of Abcg8-/- mice. Conclusion: Deletion of the Abcg8 gene alone significantly increases the mass of intestinal cholesterol and sitostanol absorption and reduces but does not eliminate hepatic secretion of cholesterol. Moreover, the mutation has no influence on acute uptake of cholesterol and sitostanol by the enterocyte nor small intestinal transit time.

UR - http://www.scopus.com/inward/record.url?scp=34247399882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247399882&partnerID=8YFLogxK

U2 - 10.1002/hep.21579

DO - 10.1002/hep.21579

M3 - Article

C2 - 17393508

AN - SCOPUS:34247399882

VL - 45

SP - 998

EP - 1006

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -